OSE Immunotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference September 14 – 16, 2020 (Virtual Conference)

NEXT STORY
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
PREV STORY
Novartis data at ACTRIMS-ECTRIMS highlight the strength of leading multiple sclerosis (MS) portfolio with life-changing therapies for people across the MS spectrum
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress

author_avatar
NASDAQ Market News

Interventional Radiology Market Size to Reach $27.3 Billion by 2024, Gastroenterology Segment to Witness Significant Growth: P&S Intelligence

author_avatar
NASDAQ Market News

Cellular Biomedicine Group Appoints Former MedImmune/AstraZeneca Director, Yihong Yao, Ph.D., B.S., as Chief Scientific Officer

SHANGHAI, China and PALO ALTO, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine ...

author_avatar
NASDAQ Market News